Medicare Advantage Plans Face Stiff Test in Twin-Power Dialysis Market

Overwhelming consolidation in the dialysis provider market, dominated nationally by two organizations, may have a chilling effect on the financial health of some Medicare Advantage plans, which hold limited negotiating power barring regulatory reform, says a new study.

Since the 21st Century Cures Act loosened enrollment rules in 2021, allowing more patients with a previous diagnosis of end-stage renal disease (ESRD) to join Medicare Advantage, plans have witnessed a significant shift. More than 40,000 fee-for-service (FFS) Medicare members with ESRD switched to an MA plan during the first Annual Election Period under the new policy, according to the consultancy Avalere.

© 2022 MMIT
Freelance Reporter

Freelance Reporter Freelance Reporter

Related Posts

stethoscope-and-money
March 17

MA Stakeholders Take Issue With Bevy of Risk-Related Proposals

READ MORE
post-default-image
May 6

MAOs Enhance Kidney Care Offerings Across Disease Spectrum

Read More
post-default-image
March 19

MA Stakeholders Urge CMS to Adjust End-Stage Renal Disease Payment Rates in 2021

Read More

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today